HRT · Vaginal estrogen
Vaginal estrogen tablet: dosing, how it works, and long-term safety.
Vaginal estrogen tablets are one of the most effective — and most under-prescribed — treatments in menopause care. Here is exactly how they work, what to expect, and why they are safe long-term.
The short answer
A vaginal estrogen tablet is a small (about 1/4 inch), dissolvable insert of low-dose estradiol — typically 10 micrograms. Placed in the vagina with a slim applicator 2–3 times per week, it restores vaginal tissue, lubrication, and pH; reduces recurrent UTIs; and improves comfort with intercourse. Systemic absorption is negligible.
Available FDA-approved options
- Vagifem 10 mcg: the original branded product.
- Yuvafem 10 mcg: AB-rated generic.
- Generic estradiol vaginal tablet 10 mcg: lowest cost.
- Imvexxy (softgel insert): 4 mcg or 10 mcg, no applicator required — different form factor, same drug class.
Dosing schedule
- Weeks 1–2 (loading): one tablet vaginally nightly.
- Week 3 onward (maintenance): one tablet twice weekly (e.g., Monday and Thursday), long-term.
- Some clinicians step to once weekly after 3 months if symptoms are fully controlled.
What it treats
- Vaginal dryness, burning, and itching
- Painful intercourse (dyspareunia)
- Recurrent urinary tract infections
- Urinary urgency and mild stress incontinence related to atrophy
- Postmenopausal spotting from atrophic tissue
What it does not treat
Hot flashes, night sweats, mood symptoms, bone loss, or cognitive symptoms. Those require systemic HRT.
Safety at a glance
- No progesterone required — even for women with a uterus.
- Serum estradiol stays in postmenopausal range on typical dosing.
- NAMS 2022 endorses long-term use.
- Cancer survivors: increasingly used with oncology sign-off; ACOG 2021 supports individualized decisions.
Sources
- NAMS 2022 Position Statement on Genitourinary Syndrome of Menopause
- ACOG Committee Opinion 659 — Vaginal Estrogen in Cancer Patients
- FDA labels — Vagifem, Yuvafem, Imvexxy
Frequently asked questions
What is a vaginal estrogen tablet?
A small, dissolvable tablet (Vagifem, Yuvafem, or generic 10 mcg estradiol) inserted into the vagina 2–3 times per week. It delivers low-dose estradiol directly to vaginal and urethral tissue with minimal systemic absorption.
How often do you use a vaginal estrogen tablet?
Standard schedule: one tablet nightly for two weeks (loading phase), then one tablet twice weekly indefinitely as maintenance. Some clinicians use once-weekly maintenance for milder symptoms.
Is a vaginal estrogen tablet the same as HRT?
No. Low-dose vaginal estrogen is considered "local therapy." Blood estradiol levels stay in the postmenopausal range, so it does not treat hot flashes, does not require progesterone, and does not carry the same systemic risks as HRT.
Do you need progesterone with vaginal estrogen?
No. Because systemic absorption is minimal, NAMS 2022 and ACOG both state that women with a uterus using low-dose vaginal estrogen do not need progesterone. Any new bleeding still requires evaluation.
How long does it take to work?
Comfort with intercourse and reduced dryness typically improve within 2–4 weeks. Full restoration of vaginal epithelium and urinary symptom improvement usually takes 8–12 weeks.
Is vaginal estrogen safe long-term?
Yes — this is one of the best-supported long-term therapies in menopause. It is safe indefinitely and, based on current evidence, is generally considered appropriate for most women with a history of estrogen-sensitive cancers as well (with oncology sign-off).
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-06-19. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.